EVAX
Evaxion Sp ADS (EVAX)
NASDAQ
$3.95+$0.20 (+5.33%)
Price as of Jun 03, 2026 5:49 PM EDT
  • $33.4M
    Market Cap
  • 36.86%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
7.5M
+125.12%
3.3M
+4,480.82%
73,000
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
7.5M
+125.12%
3.3M
+4,480.82%
73,000
N/A
0
-100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-10.0M
-4.61%
-10.5M
-12.24%
-11.9M
-30.14%
-17.1M
-12.90%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
6.8M
-10.92%
7.6M
-26.41%
10.4M
+26.15%
8.2M
+31.31%
Operating Profit
-9.2M
-37.32%
-14.7M
-33.63%
-22.2M
-12.14%
-25.3M
-2.21%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
0
N/A
0
+100.00%
-1,000
-97.06%
-34,000
+580.00%
Interest Income and Expense and Net
0
N/A
0
+100.00%
-1,000
-97.06%
-34,000
+580.00%
Total Nonoperating Income and Expense
0
N/A
0
-100.00%
1,000
-97.06%
34,000
+580.00%
Income before Taxes
-7.7M
-27.07%
-10.6M
-52.24%
-22.1M
-4.51%
-23.2M
-5.56%
Income Taxes
-908,000
+15.23%
-788,000
-0.25%
-790,000
+2.33%
-772,000
+333.71%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.7M
-27.07%
-10.6M
-52.24%
-22.1M
-4.51%
-23.2M
-5.56%
Net Income from Continuing Operations Applicable to Common
-7.7M
-27.07%
-10.6M
-52.24%
-22.1M
-4.51%
-23.2M
-5.56%
Basic EPS and Net Income
-0.02
-90.00%
-0.20
-75.31%
-0.81
-17.35%
-0.98
-22.22%
Diluted EPS and Net Income
-0.02
-90.00%
-0.20
-75.31%
-0.81
-17.35%
-0.98
-12.50%
Basic Weighted Average Shares
320.4M
+497.28%
53.6M
+96.24%
27.3M
+15.64%
23.6M
+21.27%
Diluted Weighted Average Shares
320.4M
+497.28%
53.6M
+96.24%
27.3M
+15.64%
23.6M
+21.27%
Balance Sheet
Cash and Cash Equivalents
23.2M
+290.36%
6.0M
+6.61%
5.6M
-57.65%
13.2M
-59.01%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
23.2M
+290.36%
6.0M
+6.61%
5.6M
-57.65%
13.2M
-59.01%
Total Current Assets
24.9M
+184.10%
8.8M
+4.97%
8.3M
-50.84%
17.0M
-51.06%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
3.3M
-5.46%
3.5M
N/A
N/A
N/A
4.7M
-9.64%
Total Long-Term Assets
3.5M
-5.73%
3.7M
-18.04%
4.5M
-9.94%
5.0M
-7.66%
Total Assets
28.4M
+127.54%
12.5M
-3.13%
12.9M
-41.48%
22.0M
-45.16%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.3M
-2.54%
4.4M
-38.34%
7.1M
+88.30%
3.8M
-12.98%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
7.1M
-27.20%
9.8M
-7.26%
10.5M
+5.76%
10.0M
+192.68%
Total Liabilities
11.4M
-19.58%
14.1M
-19.76%
17.6M
+28.39%
13.7M
+77.61%
Retained Earnings
-126.2M
+6.50%
-118.5M
+9.79%
-108.0M
+48.60%
-72.7M
+44.07%
Total Stockholders Equity
17.0M
N/A
N/A
N/A
-4.7M
-156.96%
8.3M
-74.40%
Total Shares Outstanding
417.0M
+494.62%
70.1M
N/A
N/A
N/A
19.2M
0.00%
Cash Flow
Cash from Operating Activities
-6.6M
-48.80%
-12.9M
-26.86%
-17.7M
-31.36%
-25.8M
+17.51%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-14,000
+366.67%
-3,000
-96.77%
-93,000
-65.30%
-268,000
-79.85%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
22.4M
+70.69%
13.1M
+22.80%
10.7M
+36.14%
7.9M
-84.23%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-122.66%
-72.16%
-440.55%
-98.55%
-30,406.85%
N/A
N/A
N/A
Return on Assets
-37.69%
-54.74%
-83.29%
-34.28%
-126.74%
+70.09%
-74.51%
-20.83%
Return on Equity
N/A
N/A
N/A
N/A
-1,238.11%
+988.54%
-113.74%
-8.49%
Revenue Growth
125.12%
-97.21%
4,480.82%
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.85
+191.51%
2.01
+70.24%
1.18
-73.89%
4.51
-43.76%
Cash Ratio
5.46
+300.54%
1.36
+72.90%
0.79
-77.51%
3.50
-52.90%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow